Delivery Order SPE2DB22D1106-SPE2DB24FDUN6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,320.61 firm fixed-price delivery order is for the supply of 4562262625 - CEFDINIR 300 MG CAPSULE 60S, with a completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,103.47, is for the delivery of 4567268097 ! CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order with a completion date of February 14, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,913.72 firm fixed price delivery order is for the supply of 4567253160 - CEFDINIR 300 MG CAPSULE 60S, with a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a $2,066.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a prescription medication. The contract has a completion date of July 11, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.66, is for the delivery of CEFDINIR 300 MG CAPSULE 60S. It is a firm fixed-price delivery order contract with a completion date of March 31, 2025. The contract was awarded on March 28, 2025 and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery...
- This federal contract award is for the delivery of 4564535230 ! CEFDINIR 300 MG CAPSULE 60S, a prescription medication, to the Defense Logistics Agency (DLA). The $1,207.09 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
- This is a $1,633.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product, with a performance period through May 13, 2025. This delivery order is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA...
- This federal contract award, valued at $2,928.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of CEFDINIR 300 MG CAPSULE 60S, a pharmaceutical product, with an ultimate completion date of October 27, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $7,804 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,492,739 units of the pharmaceutical drug Cefdinir 300 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,820.98 firm fixed price delivery order is for the supply of 4,564,404,102 units of Cefdinir 300 mg capsules. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDUN6Delivery Order
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,369.24 firm fixed price delivery order is for the supply of 4563301233 - CEFDINIR 300 MG CAPSULE 60S to support military treatment programs and facilities. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and related distribution services to the Department of Defense under DLA contracts. Additionally, the company holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to supply medical supplies and prescription medications, with a potential value of $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/11/24 |